Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Sonos
SONO
$1.93B
| $10.8M | ﹤0.01% |
596,926
+227,245
| +61% | +$5.1M |
|
|
HIBB
2502
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $10.8M | ﹤0.01% |
246,308
+104,638
| +74% | +$4.83M |
|
2503
Digital Turbine
APPS
$1.51B
| $10.8M | ﹤0.01% |
615,572
+308,748
| +101% | +$8.37M |
|
|
FRBN
2504
DELISTED
Forbion European Acquisition Corp. Class A Ordinary Shares
FRBN
| $10.8M | ﹤0.01% |
1,075,000
-1
| -0% | -$10 |
|
2505
Quest Diagnostics
DGX
$25.9B
| $10.7M | ﹤0.01% |
80,832
+77,749
| +2,522% | +$10.6M |
|
2506
Global Ship Lease
GSL
$1.52B
| $10.7M | ﹤0.01% |
650,244
+71,305
| +12% | +$1.57M |
|
|
KRTX
2507
CALL
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $10.7M | ﹤0.01% |
84,900
+50,900
| +150% | +$5.85M |
|
2508
CALL
KraneShares Global Carbon Strategy ETF
KRBN
$132M
| $10.7M | ﹤0.01% |
218,100
+40,500
| +23% | +$1.95M |
|
2509
PUT
CSX Corp
CSX
$92.9B
| $10.7M | ﹤0.01% |
369,000
-258,100
| -41% | -$8.41M |
|
2510
CALL
State Street SPDR S&P Metals & Mining ETF
XME
$4.53B
| $10.7M | ﹤0.01% |
247,000
-401,800
| -62% | -$21.8M |
|
2511
Texas Pacific Land
TPL
$24.7B
| $10.7M | ﹤0.01% |
64,800
-3,591
| -5% | -$587K |
|
2512
Elanco Animal Health
ELAN
$11.8B
| $10.7M | ﹤0.01% |
545,183
-50,132
| -8% | -$1.19M |
|
|
KCGI
2513
DELISTED
Kensington Capital Acquisition Corp. V
KCGI
| $10.7M | ﹤0.01% |
1,080,698
-527,659
| -33% | -$5.23M |
|
2514
KT
KT
$9.11B
| $10.7M | ﹤0.01% |
765,523
+645,557
| +538% | +$9.28M |
|
2515
B2Gold
BTG
$6.79B
| $10.7M | ﹤0.01% |
3,151,196
+1,513,935
| +92% | +$6.32M |
|
|
SRCL
2516
DELISTED
Stericycle Inc
SRCL
| $10.7M | ﹤0.01% |
243,513
-84,168
| -26% | -$4.17M |
|
2517
Buckle
BKE
$2.27B
| $10.7M | ﹤0.01% |
385,331
+188,499
| +96% | +$5.91M |
|
2518
ArcelorMittal
MT
$55.7B
| $10.7M | ﹤0.01% |
471,645
+626
| +0.1% | +$18.3K |
|
2519
Group 1 Automotive
GPI
$3.15B
| $10.7M | ﹤0.01% |
62,741
-44,732
| -42% | -$7.79M |
|
2520
Wipro
WIT
$19.2B
| $10.7M | ﹤0.01% |
4,012,808
+1,369,420
| +52% | +$4.31M |
|
|
RVNC
2521
DELISTED
Revance Therapeutics, Inc.
RVNC
| $10.6M | ﹤0.01% |
769,584
+104,391
| +16% | +$1.61M |
|
2522
PUT
Toyota
TM
$226B
| $10.6M | ﹤0.01% |
68,900
+12,200
| +22% | +$2.02M |
|
|
EDNC
2523
DELISTED
Endurance Acquisition Corp. Class A Ordinary Shares
EDNC
| $10.6M | ﹤0.01% |
1,078,438
-171,653
| -14% | -$1.69M |
|
2524
CALL
iShares US Home Construction ETF
ITB
$2.36B
| $10.6M | ﹤0.01% |
202,200
+37,800
| +23% | +$2.16M |
|
2525
Rollins
ROL
$17.4B
| $10.6M | ﹤0.01% |
303,971
-447,854
| -60% | -$15.4M |
|
Similar funds
Citadel Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
- Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.